Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nexus NeuroTech Ventures is a venture capital firm founded in 2023 and headquartered in San Francisco. The firm is dedicated to advancing technologies that address brain disorders, including neurodegenerative, neuropsychiatric, and neurodevelopmental conditions. These include significant health issues such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Nexus NeuroTech Ventures aims to support solutions that enhance the diagnosis, treatment, and management of these complex conditions.
As a newly established firm, Nexus NeuroTech Ventures is in the early stages of building its portfolio and operational capabilities. The firm focuses on investments in North America and is actively seeking innovative companies that align with its mission. The Nexus NeuroTech Incubator Program is a key component of their strategy, designed to support early-stage programs and foster the development of groundbreaking technologies in the brain health sector.
Nexus NeuroTech Ventures invests in a diverse range of technologies and services specifically aimed at addressing brain disorders. Their investment strategy encompasses several key areas, including software and data platforms tailored for researchers, therapy developers, and clinicians. They also focus on solutions that assist patients and caregivers in managing neurological and psychiatric conditions.
Additional areas of investment include sensors and diagnostic technologies that detect brain disorder risks and treatment responses, as well as medical devices designed to modulate or treat brain disorders. The firm is open to seed and series A-C investments, emphasizing support for innovations that enhance the diagnosis, treatment, and management of conditions like Parkinson’s disease and autism spectrum disorder. Through the Nexus NeuroTech Incubator Program, they provide resources and mentorship to early-stage companies, further solidifying their commitment to advancing brain health technologies.
Nexus NeuroTech Ventures has begun to establish its portfolio, which includes several notable companies focused on brain health innovations. Key portfolio companies include:
Jordi Parramon, PhD: General Partner & Co-Founder. Dr. Parramon has a background in neuroscience and has previously worked in various roles within the biotech industry, focusing on brain health innovations.
William J. Marks, Jr., MD, MS-HCM: General Partner & Co-Founder. Dr. Marks is a physician with extensive experience in clinical research and has led numerous projects in neurodegenerative disease management.
Jon Lundt, PhD: Principal. Dr. Lundt specializes in data analytics and has a strong background in developing software solutions for healthcare applications.
John Propst, PhD, MBA: Principal. Dr. Propst combines expertise in business and neuroscience, having worked on various healthcare startups focused on brain disorders.
Edward Ruppel III, MSE: Senior Associate. Ruppel has a background in engineering and has been involved in developing medical devices aimed at treating neurological conditions.
To pitch Nexus NeuroTech Ventures, founders should send their proposals via email to info@nexusneurotech.com. A comprehensive pitch deck is essential, including details about the technology, market potential, and team qualifications. Nexus NeuroTech Ventures appreciates clarity and conciseness in presentations.
While there is no specific application portal mentioned, founders are encouraged to provide a clear overview of their business model and how it aligns with the firm’s focus on brain health technologies. Response times may vary, but founders should expect to hear back within a few weeks.
Nexus NeuroTech Ventures operates the Nexus NeuroTech Incubator Program, which is designed to support early-stage companies developing technologies for brain disorders. This program provides resources, mentorship, and networking opportunities to help startups navigate the complexities of the healthcare sector.
Eligibility for the program typically includes early-stage companies focused on innovations in brain health. Interested founders can apply by reaching out via email to info@nexusneurotech.com for more information on the application process.
Nexus NeuroTech Ventures has been actively building its portfolio since its founding in 2023. Notable investments include companies like Ampa Health and Cala Health, which are focused on innovative solutions for brain disorders. The firm has not published any recent blog posts or updates, indicating a concentrated effort on portfolio development rather than public communications.
What are Nexus NeuroTech Ventures' investment criteria?
Nexus NeuroTech Ventures focuses on technologies and services that address brain disorders, including neurodegenerative, neuropsychiatric, and neurodevelopmental conditions. They invest in companies developing software platforms, medical devices, and therapy enabling technologies.
How can I pitch to Nexus NeuroTech Ventures?
Founders can reach out via email at info@nexusneurotech.com. A well-prepared pitch deck that outlines the technology, market opportunity, and team is essential for consideration.
What makes Nexus NeuroTech Ventures different from other VC firms?
The firm is specifically focused on brain health innovations, which allows them to provide targeted support and resources through their Nexus NeuroTech Incubator Program. This program is designed to assist early-stage companies in navigating the complexities of the healthcare sector.
What is the geographic scope of Nexus NeuroTech Ventures?
Nexus NeuroTech Ventures primarily invests in North America, seeking innovative companies that align with their focus on brain disorders.
What is the typical check size for investments?
While specific check sizes are not disclosed, Nexus NeuroTech Ventures invests across seed and series A-C stages, indicating a flexible approach to funding based on the needs of the portfolio companies.
What kind of post-investment involvement can founders expect?
Nexus NeuroTech Ventures is committed to supporting its portfolio companies through mentorship, access to resources, and potential follow-on investments, particularly through their incubator program.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.